
Dechra also bought stem cell developer Gallant, bringing gingivostomatitis and osteoarthritis programs for dogs and cats into its pipeline.
Will that new piece of equipment pull its weight in your practice?
Click here
for a handy worksheet to help you add up the numbers and figure out whether that piece of equipment is a necessity or no good for your financials.






